{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:41:38Z","timestamp":1792734098004,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ek0109615"],"award-info":[{"award-number":["JP24ek0109615"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ek0109734"],"award-info":[{"award-number":["JP24ek0109734"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grants-in-Aid from the Research Committee of Ataxia, Health Labor Sciences Research Grant, the Ministry of Health, Labor and Welfare, Japan","award":["JPMH23FC1010"],"award-info":[{"award-number":["JPMH23FC1010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anti-metabotropic glutamate receptor type 1 (mGluR1) antibody-associated cerebellar ataxia is a rare autoimmune cerebellar ataxia. Although its clinical spectrum has been recognized mainly from Western cohorts, its features in other populations remain uncharacterized. We investigated the clinical characteristics of this disease in a Japanese cohort with reference to overseas cases. We retrospectively reviewed patients testing positive for anti-mGluR1 antibodies in our laboratory between 2018 and 2025, comparing their clinical, laboratory, and radiological profiles with reference to 40 previously reported overseas cases. Of 699 screened patients, 12 were antibody-positive. Asymmetrical limb ataxia was documented in 75.0% of Japanese patients, whereas asymmetry was explicitly described in only four of twenty-eight overseas patients (14.3%) (p\u2009&lt;\u20090.001); however, this comparison is exploratory and may reflect documentation differences. Japanese patients showed lower cerebrospinal fluid (CSF) inflammatory markers, with lower cell counts (median 4.5\/\u00b5L vs. 27\/\u00b5L, p\u2009=\u20090.014) and protein levels (median 36.5 mg\/dL vs. 60.0 mg\/dL, p\u2009=\u20090.048), although neither remained significant after Bonferroni correction. Two Japanese cases developed neurological symptoms within 1 month of COVID-19 infection. Although all Japanese patients received immunotherapy (corticosteroids in 100%), long-term functional recovery remained suboptimal; among 9 patients followed for \u2265\u20096 months, only 33.3% achieved functional independence (modified Rankin Scale\u2009\u2264\u20092) at final follow-up. In this first Japanese multicenter case series, asymmetrical limb ataxia was frequently documented and CSF inflammation was often limited. These exploratory findings may generate hypotheses to facilitate earlier diagnosis and treatment, but require cautious interpretation.<\/jats:p>","DOI":"10.1007\/s12311-026-02094-z","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:33:07Z","timestamp":1790742787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics of Japanese Cases of Anti-Metabotropic Glutamate Receptor Type 1 Antibody-Associated Cerebellar Ataxia"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-8600","authenticated-orcid":false,"given":"Nobuaki","family":"Yoshikura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-2008","authenticated-orcid":false,"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takekoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7168-0623","authenticated-orcid":false,"given":"Keisuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5031-9701","authenticated-orcid":false,"given":"Reiji","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-8740","authenticated-orcid":false,"given":"Hiroaki","family":"Yaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-7997","authenticated-orcid":false,"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Maku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutaro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-9089","authenticated-orcid":false,"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2094_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.12688\/f1000research.10485.1","volume":"6","author":"M Kano","year":"2017","unstructured":"Kano M, Watanabe T. Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease. F1000Res. 2017;6:416. https:\/\/doi.org\/10.12688\/f1000research.10485.1.","journal-title":"F1000Res"},{"issue":"22","key":"2094_CR2","doi-asserted-by":"publisher","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Petit Pedrol M, Maudes E, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. 2020;95(22):e3012\u201325. https:\/\/doi.org\/10.1212\/WNL.0000000000010854.","journal-title":"Neurology"},{"issue":"1","key":"2094_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342(1):21\u20137. https:\/\/doi.org\/10.1056\/NEJM200001063420104.","journal-title":"N Engl J Med"},{"issue":"3","key":"2094_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.10451","volume":"53","author":"M Coesmans","year":"2003","unstructured":"Coesmans M, Smitt PA, Linden DJ, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol. 2003;53(3):325\u201336. https:\/\/doi.org\/10.1002\/ana.10451.","journal-title":"Ann Neurol"},{"issue":"5","key":"2094_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/archneurol.2010.51","volume":"67","author":"R Marignier","year":"2010","unstructured":"Marignier R, Chenevier F, Rogemond V, et al. Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease? Arch Neurol. 2010;67(5):627\u201330. https:\/\/doi.org\/10.1001\/archneurol.2010.51.","journal-title":"Arch Neurol"},{"issue":"18","key":"2094_CR6","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77(18):1698\u2013701. https:\/\/doi.org\/10.1212\/WNL.0b013e3182364a44.","journal-title":"Neurology"},{"issue":"1\u20132","key":"2094_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2013.07.015","volume":"263","author":"R Iorio","year":"2013","unstructured":"Iorio R, Damato V, Mirabella M, et al. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma. J Neuroimmunol. 2013;263(1\u20132):155\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.07.015.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"2094_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","volume":"86","author":"AS Lopez-Chiriboga","year":"2016","unstructured":"Lopez-Chiriboga AS, Komorowski L, Kumpfel T, et al. Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes. Neurology. 2016;86(11):1009\u201313. https:\/\/doi.org\/10.1212\/WNL.0000000000002476.","journal-title":"Neurology"},{"issue":"16","key":"2094_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1212\/WNL.0000000000005338","volume":"90","author":"JL Pedroso","year":"2018","unstructured":"Pedroso JL, Dutra LA, Espay AJ, Hoftberger R, Barsottini OGP. Video NeuroImages: Head titubation in anti-mGluR1 autoantibody-associated cerebellitis. Neurology. 2018;90(16):746\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000005338.","journal-title":"Neurology"},{"key":"2094_CR10","doi-asserted-by":"publisher","first-page":"175628641984741","DOI":"10.1177\/1756286419847418","volume":"12","author":"M Christ","year":"2019","unstructured":"Christ M, Muller T, Bien C, Hagen T, Naumann M, Bayas A. Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature. Ther Adv Neurol Disord. 2019;12:1756286419847418. https:\/\/doi.org\/10.1177\/1756286419847418.","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"2094_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mds.27634","volume":"34","author":"C Gollion","year":"2019","unstructured":"Gollion C, Dupouy J, Roberts M, et al. Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies. Mov Disord. 2019;34(3):438\u20139. https:\/\/doi.org\/10.1002\/mds.27634.","journal-title":"Mov Disord"},{"issue":"8","key":"2094_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mdc3.12841","volume":"6","author":"H Chaumont","year":"2019","unstructured":"Chaumont H, Petit A, Mameri T, Schollhammer R, Honnorat J, Lannuzel A. Successful Management of Anti-mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger? Mov Disord Clin Pract. 2019;6(8):727\u20138. https:\/\/doi.org\/10.1002\/mdc3.12841.","journal-title":"Mov Disord Clin Pract"},{"key":"2094_CR13","doi-asserted-by":"publisher","first-page":"577366","DOI":"10.1016\/j.jneuroim.2020.577366","volume":"348","author":"CG Bien","year":"2020","unstructured":"Bien CG, Braig S, Bien CI. Antibodies against metabotropic glutamate receptor type 1 in a toddler with acute cerebellitis. J Neuroimmunol. 2020;348:577366. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577366.","journal-title":"J Neuroimmunol"},{"key":"2094_CR14","doi-asserted-by":"publisher","first-page":"2329048X2210956","DOI":"10.1177\/2329048X221095695","volume":"9","author":"E Chandler","year":"2022","unstructured":"Chandler E, Arvantis N, Morgan B. A Novel Case of Idiopathic MGluR1 Encephalitis in a Pediatric Patient. Child Neurol Open. 2022;9:2329048X221095695. https:\/\/doi.org\/10.1177\/2329048X221095695.","journal-title":"Child Neurol Open"},{"key":"2094_CR15","doi-asserted-by":"publisher","unstructured":"Vinke AM, Zong S, Janssen JH, et al. Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report. Neurol Neuroimmunol Neuroinflamm. 2022;9(4). https:\/\/doi.org\/10.1212\/NXI.0000000000001171.","DOI":"10.1212\/NXI.0000000000001171"},{"issue":"19","key":"2094_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/WNL.0000000000201268","volume":"99","author":"L Goh","year":"2022","unstructured":"Goh L, Wang FS, Han VX, Lin JB. Teaching Video NeuroImage: Subacute Cerebellar Ataxia in an Adolescent With Antibodies Against Metabotropic Glutamate Receptor Type 1. Neurology. 2022;99(19):862\u20133. https:\/\/doi.org\/10.1212\/WNL.0000000000201268.","journal-title":"Neurology"},{"key":"2094_CR17","doi-asserted-by":"publisher","first-page":"1142160","DOI":"10.3389\/fneur.2023.1142160","volume":"14","author":"O Khojah","year":"2023","unstructured":"Khojah O, Makkawi S, Alghamdi S. Anti-mGluR1 encephalitis: Case illustration and systematic review. Front Neurol. 2023;14:1142160. https:\/\/doi.org\/10.3389\/fneur.2023.1142160.","journal-title":"Front Neurol"},{"key":"2094_CR18","doi-asserted-by":"publisher","first-page":"578082","DOI":"10.1016\/j.jneuroim.2023.578082","volume":"378","author":"H Wang","year":"2023","unstructured":"Wang H, Yi B, Wang M, et al. Cerebellar ataxia with anti-mGluR1 auto-antibody in a pediatric patient: A case report. J Neuroimmunol. 2023;378:578082. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578082.","journal-title":"J Neuroimmunol"},{"key":"2094_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejpn.2023.10.005","volume":"47","author":"L Quack","year":"2023","unstructured":"Quack L, Glatter S, Wegener-Panzer A, et al. Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitis. Eur J Paediatr Neurol. 2023;47:118\u201330. https:\/\/doi.org\/10.1016\/j.ejpn.2023.10.005.","journal-title":"Eur J Paediatr Neurol"},{"key":"2094_CR20","doi-asserted-by":"publisher","first-page":"1333658","DOI":"10.3389\/fneur.2024.1333658","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X, Chen Y, Di L, et al. Cerebellar encephalitis associated with anti-mGluR1 antibodies: a case report and comprehensive literature review. Front Neurol. 2024;15:1333658. https:\/\/doi.org\/10.3389\/fneur.2024.1333658.","journal-title":"Front Neurol"},{"key":"2094_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2024.03.001","volume":"50","author":"N Sachs","year":"2024","unstructured":"Sachs N, Zohar-Dayan E, Ben Zeev B, et al. Autoimmune encephalitis in Israeli children - A retrospective nationwide study. Eur J Paediatr Neurol. 2024;50:1\u20135. https:\/\/doi.org\/10.1016\/j.ejpn.2024.03.001.","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"2094_CR22","first-page":"207","volume":"77","author":"CD Tessendorf","year":"2024","unstructured":"Tessendorf CD, Hueser JF, Wechsler B, Amin NN. Gluten Ataxia and mGluR1 Autoimmune Encephalitis Presenting as Acute Cerebellar Ataxia: A Case Report. S D Med. 2024;77(5):207\u201310.","journal-title":"S D Med"},{"key":"2094_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.04.001","volume":"319","author":"N Yoshikura","year":"2018","unstructured":"Yoshikura N, Kimura A, Fukata M, et al. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.001.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2094_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1159\/000526632","volume":"14","author":"K Sakashita","year":"2022","unstructured":"Sakashita K, Nishida K, Takenaka Y, et al. Favorable Outcome with Intravenous Immunoglobulin Therapy in Late-Onset Anti-mGluR1 Encephalitis: A Case Report and Literature Review. Case Rep Neurol. 2022;14(3):494\u2013500. https:\/\/doi.org\/10.1159\/000526632.","journal-title":"Case Rep Neurol"},{"issue":"1","key":"2094_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12883-025-04345-8","volume":"25","author":"K Yamada","year":"2025","unstructured":"Yamada K, Yaguchi H, Nakamura S, et al. Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report. BMC Neurol. 2025;25(1):319. https:\/\/doi.org\/10.1186\/s12883-025-04345-8.","journal-title":"BMC Neurol"},{"issue":"10","key":"2094_CR26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/wnl.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42(10):1931\u20137. https:\/\/doi.org\/10.1212\/wnl.42.10.1931.","journal-title":"Neurology"},{"issue":"8","key":"2094_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Arino","year":"2014","unstructured":"Arino H, Gresa-Arribas N, Blanco Y, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71(8):1009\u201316. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1011.","journal-title":"JAMA Neurol"},{"key":"2094_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangue T, Planaguma J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18:1045\u201357.","journal-title":"Lancet Neurol"},{"key":"2094_CR29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92:757\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02094-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:37:14Z","timestamp":1792733834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02094-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02094-z","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"25 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Gifu University Graduate School of Medicine (authorization number 2020-001) and was performed in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants before their inclusion in the study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"148"}}